Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease

Autor: Tatenhorst, Lars, Eckermann, Katrin, Outeiro, Tiago F, Zweckstetter, Markus, Lingor, Paul, Dambeck, Vivian, Fonseca-Ornelas, Luis, Walle, Hagen, Lopes da Fonseca, Tomás, Koch, Jan C, Becker, Stefan, Tönges, Lars, Bähr, Mathias

Publikováno v: Acta Neuropathologica Communications
Acta Neuropathologica Communications 4(1), 39 (2016). doi:10.1186/s40478-016-0310-y

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, yet disease-modifying treatments do not currently exist. Rho-associated protein kinase (ROCK) was recently described as a novel neuroprotective target in PD. Since alp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e25ac157886f125890f1f46489256178
https://pubmed.ncbi.nlm.nih.gov/27101974

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease

Autor: Tatenhorst, Lars, Eckermann, Katrin, Dambeck, Vivian, Fonseca-Ornelas, Luis, Walle, Hagen, Lopes da Fonseca, Tomás, Koch, Jan C., Becker, Stefan, Tönges, Lars, Bähr, Mathias, Outeiro, Tiago F., Zweckstetter, Markus, Lingor, Paul

Publikováno v: Acta Neuropathologica Communications. 4(1)

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, yet disease-modifying treatments do not currently exist. Rho-associated protein kinase (ROCK) was recently described as a novel neuroprotective target in PD. Since alp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b370273df6978a28bd041fbd4d513dc5